Canadian research-driven cannabis extraction Company MediPharm Labs Inc. (TSX-V: LABS, OTCQB:MLCPF,Forum) was covered by leading investor news resource investorideas.com, who focuses on hemp and cannabis stocks, Wednesday. The media coverage looked at MediPharm’s recent sales agreement with a leading licensed producer to supply roughly $35 million of private label purified cannabis oil concentrates.
For more information on this, click here.
In a market work $16.9 billion, MediPharm was also covered by Arcview Market Researchearlier this week, looking further into its sales agreement with to supply about $35 million of private label purified cannabis oil concentrates.
FULL DISCLOSURE: MediPharm Labs Inc. is a client of Stockhouse Publishing.